Tamsulosin

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alpha adrenergic blockers, Cimetidine, Conivaptan, Darunavir, Delavirdine, Erythromycin, Indinavir, Ketoconazole, Paroxetine Hydrochloride, Phosphodiesterase 5 inhibitors, Tadalafil, Telithromycin, Terbinafine, Vardenafil, Voriconazole, Warfarin

PREGNANCY CATEGORY: B
not indicated for use in women; Jalyn is pregnancy category X

Jalyn is tamsulosin and dutasteride.

Our database has 46 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top